Showing results (1151-1160 of 1,287) with videos related to

Sort By:
Pageof 129
Cancer Biology & Therapy|October 25, 2023
Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistanceDavid J Zahavi, Rossin Erbe, Yong-Wei Zhang, et al.
Journal for Immunotherapy of Cancer|November 5, 2021
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinomaAllison A Fitzgerald, Shangzi Wang, Veena Agarwal, et al.
NAR Molecular Medicine|January 12, 2026
Transcript-Capture sequencing enriches mRNA of Mycobacterium tuberculosis from host samplesEleanor I Lamont, Richard M Jones, Jessica Assadi, et al.
Infection Control and Hospital Epidemiology|November 26, 2019
Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017Lindsey M Weiner-Lastinger, Sheila Abner, Andrea L Benin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinomaM von Mehren, P Arlen, J Gulley, et al.
Current Pharmaceutical Design|May 23, 2006
Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readoutEthan S Burstein, Fabrice Piu, Jian-Nong Ma, et al.
Cancer Immunology, Immunotherapy : CII|August 16, 2011
Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatmentShangzi Wang, Igor A Astsaturov, Catherine A Bingham, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transcript-Capture sequencing enriches mRNA of Mycobacterium tuberculosis from host samplesEleanor I Lamont, Richard M Jones, Jessica Assadi, et al.
Cancer Biology & Therapy|November 23, 2007
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancerKalyani Narra, Stefanie R Mullins, Hyung-Ok Lee, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Natural killer cells associate with epithelial cells in the pancreatic ductal adenocarcinoma tumor microenvironmentZoe X Malchiodi, Robert K Suter, Atul Deshpande, et al.
Pageof 129